MAINA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 31.671
EU - Europa 25.797
AS - Asia 20.270
SA - Sud America 3.438
AF - Africa 497
OC - Oceania 422
Continente sconosciuto - Info sul continente non disponibili 66
Totale 82.161
Nazione #
US - Stati Uniti d'America 30.484
IT - Italia 11.092
SG - Singapore 7.235
CN - Cina 5.512
FR - Francia 2.759
BR - Brasile 2.486
VN - Vietnam 2.149
IE - Irlanda 1.972
DE - Germania 1.642
KR - Corea 1.343
SE - Svezia 1.245
GB - Regno Unito 1.197
UA - Ucraina 1.136
FI - Finlandia 1.114
CA - Canada 728
PL - Polonia 717
IN - India 678
HK - Hong Kong 665
NL - Olanda 663
JP - Giappone 647
ES - Italia 521
TR - Turchia 378
AU - Australia 349
MX - Messico 328
RU - Federazione Russa 320
AR - Argentina 284
ID - Indonesia 264
BD - Bangladesh 244
CH - Svizzera 198
TW - Taiwan 189
IQ - Iraq 181
BE - Belgio 176
AT - Austria 169
CL - Cile 165
CO - Colombia 155
GR - Grecia 133
PT - Portogallo 133
EC - Ecuador 131
RO - Romania 131
DK - Danimarca 118
ZA - Sudafrica 109
TH - Thailandia 90
PK - Pakistan 89
EG - Egitto 83
PE - Perù 82
IR - Iran 76
NZ - Nuova Zelanda 73
NO - Norvegia 62
SA - Arabia Saudita 62
IL - Israele 61
TN - Tunisia 59
EU - Europa 58
MA - Marocco 57
PH - Filippine 55
PY - Paraguay 50
VE - Venezuela 47
MY - Malesia 42
UZ - Uzbekistan 41
LT - Lituania 38
KE - Kenya 36
JO - Giordania 32
NP - Nepal 32
CZ - Repubblica Ceca 30
DZ - Algeria 30
NG - Nigeria 29
RS - Serbia 29
HU - Ungheria 27
CR - Costa Rica 25
AE - Emirati Arabi Uniti 24
AZ - Azerbaigian 24
HR - Croazia 24
LB - Libano 24
AL - Albania 23
SI - Slovenia 23
UY - Uruguay 22
SK - Slovacchia (Repubblica Slovacca) 20
ET - Etiopia 18
JM - Giamaica 18
IS - Islanda 16
LK - Sri Lanka 15
BG - Bulgaria 14
KZ - Kazakistan 14
SN - Senegal 14
BO - Bolivia 12
DO - Repubblica Dominicana 12
OM - Oman 12
BY - Bielorussia 11
PA - Panama 11
PS - Palestinian Territory 11
GE - Georgia 10
GT - Guatemala 10
LV - Lettonia 10
MU - Mauritius 10
TT - Trinidad e Tobago 10
NI - Nicaragua 9
AO - Angola 8
BA - Bosnia-Erzegovina 8
HN - Honduras 8
MD - Moldavia 8
QA - Qatar 8
Totale 81.996
Città #
Singapore 4.014
Beijing 3.021
San Jose 2.488
Houston 2.263
Chandler 2.185
Santa Clara 1.992
Dublin 1.948
Ashburn 1.770
Milan 965
Villeurbanne 897
Jacksonville 884
Fairfield 860
Rome 694
Medford 648
The Dalles 629
Ann Arbor 602
Princeton 602
Ho Chi Minh City 589
Columbus 585
Lauterbourg 556
Los Angeles 555
Warsaw 548
Wilmington 544
Redwood City 542
Dallas 534
Woodbridge 528
Torino 518
Turin 518
Hong Kong 497
Hanoi 432
Seattle 422
Nyköping 384
Buffalo 373
Seoul 373
Tokyo 349
Cambridge 318
Hefei 315
Dearborn 304
Boston 278
New York 271
São Paulo 266
Pisa 260
Naples 202
Dong Ket 199
Boardman 192
Guangzhou 177
Toronto 174
Florence 166
Verona 151
Helsinki 147
Bologna 145
Shanghai 140
Council Bluffs 135
Jakarta 135
Bengaluru 132
London 129
Nanjing 109
Vienna 105
Istanbul 103
Orem 103
Palermo 103
Ottawa 102
Taipei 99
Norwalk 96
Chicago 92
Santiago 92
Brussels 87
Des Moines 86
Redondo Beach 86
Amsterdam 83
Bari 83
Frankfurt am Main 82
Genoa 81
Haiphong 81
Paris 79
Mexico City 77
Hangzhou 75
Munich 75
Stockholm 74
Sydney 72
Madrid 70
Chennai 69
Da Nang 69
Perugia 69
Catania 68
Padova 68
Rio de Janeiro 68
Fremont 67
San Diego 67
Belo Horizonte 65
Baghdad 64
Nuremberg 64
Brooklyn 61
Montreal 61
Piemonte 61
Atlanta 59
Washington 57
Barcelona 54
Chengdu 54
Falls Church 53
Totale 42.938
Nome #
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder. 3.307
Disturbi bipolari e d’ansia: aspetti epidemiologici e clinici. 3.096
Trattamento con litio e potenziali effetti collaterali a lungo termine: una revisione sistematica della letteratura 1.718
Duloxetina e bupropione in pazienti con disturbo depressivo maggiore resistente agli SSRI 1.095
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 1.053
Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists. 929
Paliperidone palmitate and metabolic syndrome in patients with schizophrenia a 12-month observational prospective cohort study 722
Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder 707
Lithium-associated hyperparathyroidism and hypercalcaemia: A case-control cross-sectional study 570
Involuntary admissions in Italy: the impact of seasonality 558
Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women. 545
Il temperamento ciclotimico nei pazienti con DOC. 525
Glucose metabolism alterations in patients with bipolar disorder. 517
Stressful life events and obsessive-compulsive disorder: clinical features and symptom dimensions 501
A randomized, single-blind comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression 496
Combining drug and psychological treatments for obsessive-compulsive disorder: What is the evidence, when and for whom 485
Increased uric acid levels in bipolar disorder subjects during different phases of illness. 474
Gender-related distribution of personality disorders in a sample of patients with panic disorder. 466
Affective recurrences in bipolar disorder after switching from lithium to valproate or vice versa: A series of 57 cases 466
Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder 439
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 425
High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder 416
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 386
Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates 386
Metabolic syndrome and Obsessive-Compulsive Disorder: a naturalistic Italian study 381
Anti-brain antibodies in adult patients with obsessive-compulsive disorder 367
Brief dynamic therapy and depression severity: a single-blind, randomized study. 367
Diagnostic delay in ADHD: Duration of untreated illness and its socio-demographic and clinical predictors in a sample of adult outpatients 364
Sindrome metabolica e disturbi psichiatrici: confronto tra disturbo bipolare e disturbo ossessivo-compulsivo 356
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain. 355
Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder. 337
Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: A case-control study 335
The concept of mixed state in bipolar disorder: from Kraepelin to DSM-5 335
Mania mista e antidepressivi: uno studio clinico su un campione di pazienti ricoverati per disturbo bipolare 332
General Medical Conditions Are Associated With Delay to Treatment in Patients with Bipolar Disorder. 327
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 315
Onset of obsessive-compulsive disorder: premorbid conditions and prodromal phase 309
Anticorpi anti-SNC in adulti con disturbo ossessivo-compulsivo 309
No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression 307
The role of the potassium channel gene KCNK2 in major depressive disorder 298
Validity and reliability of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire. 295
Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: Long-term results 294
Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study 284
Cyclothymic temperament and major depressive disorder: A study on Italian patients 282
Obsessive-compulsive disorder and cyclothymic temperament: an exploration of clinical features 274
Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study. 252
The use of antidepressants in bipolar disorder 237
Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder 237
Differenze di genere nel disturbo ossessivo-compulsivo: uno studio clinico su 415 pazienti. 236
Terapia farmacologica della distimia: uno studio di confronto fra amisulpride, fluoxetina e lorazepam 233
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 232
Efficacia e tollerabilità della Lofepramina nel trattamento della depressione nel paziente ambulatoriale 230
Il disturbo ossessivo-compulsivo di personalità (DOCP): prevalenza nei pazienti con disturbi d'ansia e nei soggetti sani 227
Correlates of violent suicide attempts in patients with bipolar disorder 223
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 220
Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study. 219
Paziente ricoverato per episodio maniacale : trattamento con asenapina in acuto e nel lungo termine 216
La stimolazione del nervo vago (VNS) nel trattamento della depressione maggiore resistente: risultati preliminari di uno studio clinico sperimentale spontaneo 208
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. 207
Impact of comorbid obsessive-compulsive disorder on suicidality in patients with bipolar disorder 207
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 207
Bipolar disorders: is there an influence of seasonality or photoperiod? 201
Early childhood infections, antistreptococcal and basal ganglia antibodies in adult ADHD: a preliminary study 200
Il disturbo ossessivo-compulsivo. Epidemiologia e clinica. 199
Delirium and COVID-19: prevalence, outcomes and associated factors in a cohort of elderly inpatients 195
Combined treatments in obsessive-compulsive disorder: current knowledge and future prospects. 194
L’inquadramento nosografico dei disturbi dell’umore: dai sintomi alla diagnosi, dalla diagnosi alla terapia. 192
Age at Menarche in Women With Bipolar Disorder: Correlation With Clinical Features and Peripartum Episodes 191
Disturbo ossessivo-compulsivo sottosoglia 187
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy. 187
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group 186
Psychiatric and physical rehabilitation intensive approach for suicide attempters by jumping from heights 186
ADHD nell’adulto e spettro Ossessivo-Compulsivo 185
Age at menarche and course of bipolar illness 184
Can quetiapine extended release (ER) induce labial edema in a female patient with treatment-resistant major depressive episode? 183
Disturbo ossessivo-compulsivo con concomitanti disturbi da uso di sostanze: uno studio clinico 182
Effectiveness of cognitive-behavioural therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study. 178
Factors associated with involuntary admissions: a register-based cross-sectional multicenter study 177
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia. 175
Unusual persistent tactile hallucinations in three adolescent patients after minimal cannabis use 174
[The general practitioner and psychiatric assistance. A study carried out in the Piedmont region] 170
Tecniche di stimolazione cerebrale nel trattamento della depressione resistente [Brain stimulation therapies for treatment-resistant depression]. 170
A 10-year evaluation on adolescents with anxiety disorders: are they at risk of bipolarity? 170
Hoarding e disturbo ossessivo-compulsivo (DOC): due entità cliniche distinte in comorbilità o hoarding secondario al DOC? 169
[Generalized anxiety disorder. Clinical and nosological remarks] 168
Common and specific blood microRNA alterations in unipolar and bipolar depression 168
The Impact of General Medical Conditions in Obsessive-Compulsive Disorder 168
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 167
Gender related differences in the onset of panic disorder 165
Ansia e disturbo bipolare: comorbilità o epifenomeno? 165
Episodic and chronic obsessive-compulsive disorder. 164
[Validity and reliability of Quality of Life, Enjoyment and Satisfaction Questionnaire, Short Form] 164
Trattamento farmacologico con sali di litio in pazienti affetti da disturbo bipolare: cosa succede al metabolismo del calcio? 163
L’intervento psicoeducazionale multifamiliare nel disturbo ossessivo-compulsivo 162
Axis II comorbidity in euthymic bipolar disorder patients: no differences between bipolar I and II subtypes 162
A systematic review of evidence-based treatment strategies for obsessive- compulsive disorder resistant to first-line pharmacotherapy 160
Treatment-resistent obsessive-compulsive disorder (OCD): current knowledge and open questions 159
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia. 158
Definizione e strategie terapeutiche della depressione resistente al trattamento: una revisione della letteratura 154
(Ipo)mania farmacoindotta e trattamenti antidepressivi con inibitori selettivi del re-uptake 154
Totale 37.532
Categoria #
all - tutte 232.393
article - articoli 0
book - libri 0
conference - conferenze 58.735
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 291.128


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021667 0 0 0 0 0 0 0 0 0 0 0 667
2021/20225.256 307 252 326 303 326 255 364 377 348 276 712 1.410
2022/20238.359 889 545 335 730 699 2.138 710 556 748 243 485 281
2023/20245.074 492 665 277 349 342 488 273 397 84 417 508 782
2024/202512.639 355 862 622 1.044 2.689 1.056 480 668 1.336 910 851 1.766
2025/202623.955 1.982 1.445 1.690 2.978 2.623 1.567 3.456 1.394 2.129 2.980 1.375 336
Totale 84.388